The Role of Immune Cells in Moyamoya Disease

Sheng Wang1,2, Qian Jiang1,2, Yuan Liu1,2

  • 1Department of Neurosurgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, China.

Brain Sciences
|February 26, 2025
PubMed

Insights

Moyamoya disease (MMD) involves immune cells like T cells and macrophages contributing to cerebrovascular inflammation and arterial stenosis. Understanding these immune mechanisms may reveal new therapeutic targets for MMD.

Area of Science:

  • Neuroscience
  • Immunology
  • Vascular Biology

Background:

  • Moyamoya disease (MMD) is a rare cerebrovascular disorder causing internal carotid artery stenosis and abnormal collateral networks.
  • The exact cause of MMD is unknown, but immune system dysfunction is increasingly implicated in its pathogenesis.
  • Immune cells, including T cells, macrophages, and dendritic cells, are recognized for their role in MMD's inflammatory processes and vascular remodeling.

Purpose of the Study:

  • To provide a comprehensive review of the immunological mechanisms in MMD.
  • To elucidate the role of immune cells in cerebrovascular injury and remodeling in MMD patients.
  • To identify potential immune-related therapeutic targets for MMD.

Main Methods:

  • Literature review of studies investigating immune cell involvement in Moyamoya disease.
  • Analysis of research on inflammatory processes and vascular remodeling in MMD.
  • Synthesis of findings on genetic and environmental factors influencing immune activation in MMD.

Main Results:

  • Immune cells significantly contribute to the inflammatory milieu and vascular remodeling characteristic of MMD.
  • Immune-mediated damage to vessel walls exacerbates arterial stenosis and ischemic events.
  • Genetic and environmental factors interplay with immune pathways in MMD development.

Conclusions:

  • Immune system dysfunction is a critical factor in Moyamoya disease pathogenesis.
  • Immune cells actively participate in the vascular injury and remodeling processes in MMD.
  • Targeting immunological pathways presents a promising avenue for novel MMD therapies.